pazopanib and Diabetes-Mellitus--Type-2

pazopanib has been researched along with Diabetes-Mellitus--Type-2* in 1 studies

1 other study(ies) available for pazopanib and Diabetes-Mellitus--Type-2

Article	Year
Improved glycemic control with the multi-receptor tyrosine kinase inhibitor pazopanib. Diabetes care, 2010, Volume: 33, Issue:6 Topics: Aged; Antibiotics, Antineoplastic; Blood Glucose; Diabetes Mellitus, Type 2; Epirubicin; Humans; Hypoglycemic Agents; Indazoles; Male; Prostatic Neoplasms; Pyrimidines; Sulfonamides	2010